The World Prison Brief is an online database providing free access to information on prison systems around the world. It is a unique resource, which supports evidence-based development of prison policy and practice globally. [internet]. WPB. 2018 [cited 2023 11.01]. 3. [https://www.prisonstudies.org/#:~:text=The%20latest%20World%20Prison%20Population,of%2011.5%20million%20prisoners%20worldwide]
Highest to Lowest. – Prison Population Total: world prison brief; 2023 [updated 2023]. https://www.prisonstudies.org/highest-to-lowest/prison-population-total/trackback?field_region_taxonomy_tid=All
Mehmandoost S, Khezri M, Mousavian G, Tavakoli F, Mehrabi F, Sharifi H, et al. Prevalence of HIV, Hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis. Public Health. 2022;203:75–82.
Shahesmaeili A, Shokoohi M, Tavakoli F, Rabiee MH, Kamali K, Haghdoost AA, et al. Prevalence of Symptom-based sexually transmitted infections and related factors among incarcerated men in Iran, 2013. Med J Islamic Repub Iran. 2021;35:185.
Hosseinkhani Z, Mohammadkhanloo M, Zamanian M, Moradzadeh R, Ramezani M, Cheraghi Z, et al. Prevalence of alcohol consumption in most at-risk groups in Iran: a systematic review and meta-analysis. J Subst Use. 2023;28(2):135–42.
Zamani S, Farnia M, Torknejad A, Abbasi Alaei B, Gholizadeh M, Kasraee F, et al. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urb Health. 2010;87:603–16.
Massoglia M, Remster B. Linkages between incarceration and health. Public Health Rep. 2019;134(1suppl):S8–14.
Rafi Bazrafshan M, Sharif F, Molazem Z, Mani A. The effect of paternal addiction on adolescent suicide attempts: a qualitative study. Int J High Risk Behav Addict. 2016;5(3):e22588.
Moradi G, Darvishi S, Asaadi L, Azimian Zavareh F, Gouya MM, Tashakorian M, et al. Patterns of Drug Use and related factors among prisoners in Iran: results from the National Survey in 2015. J Prim Prev. 2020;41(1):29–38.
Jalilian F, irzaei Alavijeh M, Amoei MR, Zinat Motlagh F, Hatamzadeh N, Allahverdipour H. Prevalence and pattern of drug abuse among prisoners in Kermanshah City. Iran J Health Educ Health Promotion. 2013;1(2):41–50.
Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006;3:1–5.
Moradi G, Jafari S, Zarei B, Mahboobi M, Zavareh FA, Molaeipoor L et al. Prevalence and risk factors for hepatitis B and hepatitis C exposure in Iranian prisoners: a national study in 2016. Hepat Monthly. 2019;19(7).
Hamzeh B, Najafi F, Heydarpour F, Moradinazar M, Moradinazar Z. The main factors affecting the tendency for Injection Drug Use. Int J High Risk Behav Addict. 2018;7(3):e12646.
Ekhtiari H, Noroozi A, Farhoudian A, Radfar SR, Hajebi A, Sefatian S, et al. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? Addiction. 2020;115(7):1395–403.
SeyedAlinaghi S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, Abedinzadeh N, McFarland W, et al. HIV in Iran: onset, responses, and future directions. AIDS. 2021;35(4):529–42.
Mehrabi F, Mehmandoost S, Khezri M, Mousavian G, Tavakoli F, Fathi HR, et al. Drug use and unsafe injection among adults who live in prisons in Iran: a systematic review and meta-analysis. Drugs: Educ Prev Policy. 2024;31(2):179–88.
Moradi G, Gouya MM, Azimizan Zavareh F, Mohamadi Bolbanabad A, Darvishi S, Aghasadeghi MR, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015. Tropical Med Int Health. 2018;23(6):641–9.
Narenjiha H, Rafiei H, Baghestani A, Nouri R, Ghafouri B, Soleimaninia L. Rapid situation assessment of drug abuse in Iran (year 2007). Tehran: Danjeh Publication; 2009.
Shahesmaeili A, Karamouzian M, Tavakoli F, Shokoohi M, Mirzazadeh A, Hosseini-Hooshyar S, et al. HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017. Harm Reduct J. 2022;19(1):93.
Navadeh S, Mirzazadeh A, Gouya MM, Farnia M, Alasvand R, Haghdoost A-A. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009. Sex Transm Infect. 2013;89(Suppl 3):iii33–6.
Dohoo IR, Martin SW, Stryhn H. Methods in epidemiologic research Charlottetown. P.E.I.: VER, Inc.; 2012.
Sánchez FC, Fearn N, Vaughn MG. Prevalence and correlates of in-prison substance use among incarcerated women in Spain. J Ethn Subst Abuse. 2018;17(3):356–74.
Norman C. A global review of prison drug smuggling routes and trends in the usage of drugs in prisons. WIREs Forensic Sci. 2023;5(2):e1473.
Lintonen TP, Vartiainen H, Aarnio J, Hakamäki S, Viitanen P, Wuolijoki T, Joukamaa M. Drug use among prisoners: by any definition, it’s a big problem. Subst Use Misuse. 2011;46(4):440–51.
Mohseni F, Moghimi Khorasani E, Nadi Ghara AA, Rafaiee R. Arrestees substance abuse: moving toward Rehabilitation camps or prisons. Iran Rehabilitation J. 2020;18(1):65–72.
Amin-Esmaeili M, Rahimi‐Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016;111(10):1836–47.
Crepault J-F, Russell C, Watson TM, Strike C, Bonato S, Rehm J. What is a public health approach to substance use? A qualitative systematic review and thematic synthesis. Int J Drug Policy. 2023;112:103958.
Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatry. 2015;16:78–83.
Amiri Z, Mirzaee B, Sabet M. Evaluating the efficacy of regulated 12-Session Matrix Model in reducing susceptibility in methamphetamine-dependent individuals. Int J Med Res Health Sci. 2016;5(2):77–85.
Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, et al. Treatment of stimulant use disorder: a systematic review of reviews. PLoS ONE. 2020;15(6):e0234809.
Fahmy C. First weeks out: social support stability and health among formerly incarcerated men. Soc Sci Med. 2021;282:114141.
Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14:e60–6.
Boys A, Farrell M, Bebbington P, Brugha T, Coid J, Jenkins R, et al. Drug use and initiation in prison: results from a national prison survey in England and Wales. Addiction. 2002;97(12):1551–60.
Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.
Håkansson A, Berglund M. Risk factors for criminal recidivism–a prospective follow-up study in prisoners with substance abuse. BMC Psychiatry. 2012;12:1–8.
Yukhnenko D, Blackwood N, Fazel S. Risk factors for recidivism in individuals receiving community sentences: a systematic review and meta-analysis. CNS Spectr. 2020;25(2):252–63.
Add Comment